ANN ABRAHAM: Open Payments
NPI 1447795182 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 47 payments from 12 companies in 2025. Trend: 2023 $964 · 2024 $807 · 2025 $1,103
Food & beverage: $1,103
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $231 |
| Indivior Inc. | 13 | $210 |
| Braeburn Inc. | 10 | $193 |
| Janssen Pharmaceuticals, Inc | 4 | $126 |
| Alkermes, Inc. | 4 | $101 |
| Neurocrine BioSciences, Inc. | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: SUBLOCADE, Wegovy, BRIXADI, INVEGA SUSTENNA, INGREZZA, VIVITROL, ARISTADA, UZEDY.
Industry payments across CA — which companies pay providers there.
